vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and Primis Financial Corp. (FRST). Click either name above to swap in a different company.

Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $34.4M, roughly 1.3× CareCloud, Inc.). Over the past eight quarters, CareCloud, Inc.'s revenue compounded faster (15.1% CAGR vs 13.0%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.

CCLD vs FRST — Head-to-Head

Bigger by revenue
FRST
FRST
1.3× larger
FRST
$45.6M
$34.4M
CCLD
Faster 2-yr revenue CAGR
CCLD
CCLD
Annualised
CCLD
15.1%
13.0%
FRST

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCLD
CCLD
FRST
FRST
Revenue
$34.4M
$45.6M
Net Profit
$7.3M
Gross Margin
Operating Margin
9.1%
Net Margin
16.0%
Revenue YoY
21.9%
Net Profit YoY
200.0%
EPS (diluted)
$0.06
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
FRST
FRST
Q1 26
$45.6M
Q4 25
$34.4M
$80.9M
Q3 25
$31.1M
$41.0M
Q2 25
$27.4M
$43.2M
Q1 25
$27.6M
$58.7M
Q4 24
$28.2M
$38.8M
Q3 24
$28.5M
$37.3M
Q2 24
$28.1M
$35.7M
Net Profit
CCLD
CCLD
FRST
FRST
Q1 26
$7.3M
Q4 25
$29.5M
Q3 25
$3.1M
$6.8M
Q2 25
$2.9M
$2.4M
Q1 25
$1.9M
$22.6M
Q4 24
$-26.2M
Q3 24
$3.1M
$1.2M
Q2 24
$1.7M
$3.4M
Operating Margin
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
9.1%
44.8%
Q3 25
10.3%
21.3%
Q2 25
10.9%
6.9%
Q1 25
7.3%
41.9%
Q4 24
12.2%
-123.0%
Q3 24
11.4%
-3.1%
Q2 24
8.1%
7.8%
Net Margin
CCLD
CCLD
FRST
FRST
Q1 26
16.0%
Q4 25
36.5%
Q3 25
9.8%
16.7%
Q2 25
10.6%
5.6%
Q1 25
7.0%
38.6%
Q4 24
-100.3%
Q3 24
10.9%
3.3%
Q2 24
6.0%
9.6%
EPS (diluted)
CCLD
CCLD
FRST
FRST
Q1 26
$0.30
Q4 25
$0.06
$1.19
Q3 25
$0.04
$0.28
Q2 25
$0.04
$0.10
Q1 25
$-0.04
$0.92
Q4 24
$0.00
$-0.95
Q3 24
$-0.04
$0.05
Q2 24
$-0.14
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
FRST
FRST
Cash + ST InvestmentsLiquidity on hand
$159.9M
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$427.2M
Total Assets
$87.6M
$4.3B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCLD
CCLD
FRST
FRST
Q1 26
$159.9M
Q4 25
$143.6M
Q3 25
$63.9M
Q2 25
$94.1M
Q1 25
$57.0M
Q4 24
$64.5M
Q3 24
$77.3M
Q2 24
$66.6M
Total Debt
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Stockholders' Equity
CCLD
CCLD
FRST
FRST
Q1 26
$427.2M
Q4 25
$59.5M
$422.9M
Q3 25
$57.8M
$382.2M
Q2 25
$56.1M
$376.4M
Q1 25
$54.2M
$375.6M
Q4 24
$49.8M
$351.8M
Q3 24
$46.5M
$381.0M
Q2 24
$43.2M
$376.0M
Total Assets
CCLD
CCLD
FRST
FRST
Q1 26
$4.3B
Q4 25
$87.6M
$4.0B
Q3 25
$90.6M
$4.0B
Q2 25
$75.2M
$3.9B
Q1 25
$73.6M
$3.7B
Q4 24
$71.6M
$3.7B
Q3 24
$70.7M
$4.0B
Q2 24
$74.0M
$4.0B
Debt / Equity
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
FRST
FRST
Operating Cash FlowLast quarter
$8.7M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
6.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
$8.7M
$10.8M
Q3 25
$7.4M
$-11.4M
Q2 25
$7.4M
$-41.0M
Q1 25
$5.1M
$34.4M
Q4 24
$5.2M
$19.5M
Q3 24
$7.1M
$6.1M
Q2 24
$4.3M
$52.3M
Free Cash Flow
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
$6.6M
$9.0M
Q3 25
$6.5M
Q2 25
$6.2M
Q1 25
$4.5M
Q4 24
$4.3M
$18.3M
Q3 24
$6.7M
Q2 24
$4.2M
FCF Margin
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
19.0%
11.2%
Q3 25
20.9%
Q2 25
22.8%
Q1 25
16.2%
Q4 24
15.2%
47.3%
Q3 24
23.6%
Q2 24
14.8%
Capex Intensity
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
6.2%
2.1%
Q3 25
2.8%
Q2 25
4.2%
Q1 25
2.3%
Q4 24
3.3%
3.1%
Q3 24
1.2%
0.0%
Q2 24
0.5%
0.0%
Cash Conversion
CCLD
CCLD
FRST
FRST
Q1 26
Q4 25
0.36×
Q3 25
2.41×
-1.67×
Q2 25
2.55×
-16.82×
Q1 25
2.62×
1.52×
Q4 24
Q3 24
2.26×
4.93×
Q2 24
2.56×
15.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

FRST
FRST

Net Interest Income$32.1M70%
Noninterest Income$13.6M30%

Related Comparisons